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• Lateral temporal lobe tracts 
 
Clusters of increased track density in Parkinson’s disease 
• Cerebellum, cerebellar peduncle cluster 
• Track-weighted imaging has potential for wide use [1,2,3,8,9] 
• Guidelines need to be developed and validated 
• Fiber count and voxel-sizes, length-scaling 
• Spatial and intensity normalization 
• Statistical testing (e.g. covariates, follow VBM best practices?) 
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Global accuracy: 86.1% Predictive Value (ValVal, Met carriers): 94.4%, 77.8% 
• Track density imaging can detect white matter changes in Parkinson’s disease 
• Significantly increased TDI clusters in patients with Parkinson’s disease 
• Cluster locations appear biologically plausible 
• No clear trend with time since disease onset 
• More quantitative than FA but unclear what exactly is being resolved 
 
TRACK DENSITY IMAGING 
• Artificial contrast created by tractography streamlines [1,2,3] 
• Resolution above original scan (“super-resolution”) is possible [1,2,3] 
• White matter accuracy validated histologically in mice [3] 
DIFFUSION-WEIGHTED IMAGING & PARKINSON’S DISEASE 
• Previous studies have found fractional anisotropy and mean diffusivity 
changes in Parkinson’s disease [4] 
• Novel MRI Biomarkers of PD are required for animal studies and drug 
development 
EXPERIMENTAL DESIGN 
• Population (n = 53, 26 healthy controls, 27 with Parkinson’s disease) 
• Age, sex, and education-matched groups 
• Magnetization Transfer volume for segmentation (1 x 1 x 1 mm3 voxels) 
• Diffusion-weighted MRI (2.4 x 2.4 x 2.4 mm3 voxels) 
• 120 directions with two b-values (b=1000, b=2500)  
• 22 interleaved b=0 volumes 
PROCESSING PIPELINE 
• Noise & motion correction, b-vecs rotated [5] 
• Constrained spherical deconvolution to 
obtain orientation distribution functions [6,7] 
• Probabilistic fiber tractography 
• 2 million tracks 
• Total streamlines counted within each 
voxel of 1 x 1 x 1 mm3 grid [1,2,3] 
• TDI maps normalized to MNI space 
• Initial affine transformation 
• Secondary non-linear warping 
• Basic SPM two-sample t-test 
• No intensity normalization 
 
 
TDI vs. Fractional Anisotropy 
• Intensity is dependent on 
processing steps taken 
• More quantitative value 
• Increased resolution 
FA map (13.8 mm3) Track Density (1 mm3) 
• Tract superior to substantia nigra 
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